Gianluca Gaidano Selected Research

Chlorambucil (Leukeran)

1/2020	A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
11/2018	Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies.
1/2017	A MALT lymphoma prognostic index.
12/2015	Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianluca Gaidano Research Topics

Disease

82	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2022 - 05/2002
64	Neoplasms (Cancer) 06/2022 - 01/2002
31	Lymphoma (Lymphomas) 01/2021 - 07/2002
26	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2002
17	Multiple Myeloma 01/2022 - 05/2002
13	Disease Progression 12/2021 - 08/2003
12	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021 - 01/2003
12	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2014 - 11/2003
9	COVID-19 11/2022 - 07/2020
8	Leukemia 01/2022 - 10/2011
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 02/2012
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 03/2011
6	Infections 01/2022 - 08/2003
6	Residual Neoplasm 12/2021 - 09/2014
6	Hemorrhage 01/2021 - 06/2004
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 02/2006
5	Neutropenia 01/2021 - 09/2015
5	Thrombocytopenia (Thrombopenia) 12/2018 - 06/2014
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2015 - 12/2002
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 02/2012
4	Acquired Immunodeficiency Syndrome (AIDS) 03/2007 - 01/2002
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2016
3	Hypoxia (Hypoxemia) 01/2020 - 11/2016
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2018 - 11/2013
3	Lymphocytosis 01/2018 - 06/2009
3	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 05/2002
3	Pneumonia (Pneumonitis) 04/2016 - 09/2015
3	Fatigue 12/2015 - 02/2015
3	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2004 - 01/2002
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022 - 02/2004
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 08/2012
2	Hairy Cell Leukemia 01/2021 - 05/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 10/2015
2	Injection Site Reaction 01/2019 - 11/2015

Drug/Important Bio-Agent (IBA)

34	Rituximab (Mabthera)FDA Link 01/2022 - 12/2002
20	Biological ProductsIBA 01/2022 - 05/2002
19	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 01/2002
17	ibrutinibIBA 06/2022 - 03/2014
15	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 05/2002
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2002
10	Lenalidomide (CC 5013)FDA Link 01/2021 - 11/2013
10	fludarabineIBA 01/2020 - 12/2011
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
9	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2012
9	Pharmaceutical PreparationsIBA 01/2021 - 01/2007
9	Prednisone (Sone)FDA LinkGeneric 01/2018 - 01/2003
8	Bendamustine Hydrochloride FDA Link 01/2021 - 07/2012
8	AntigensIBA 01/2019 - 12/2006
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2003
8	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2018 - 05/2002
7	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 01/2003
6	LigandsIBA 04/2022 - 02/2003
6	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2016
5	Circulating Tumor DNAIBA 06/2022 - 01/2018
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 09/2004
5	Bortezomib (Velcade)FDA Link 10/2017 - 12/2010
5	Azacitidine (5 Azacytidine)FDA Link 04/2016 - 02/2012
4	Cell-Free Nucleic AcidsIBA 06/2022 - 01/2017
4	carfilzomibIBA 01/2021 - 01/2016
4	Monoclonal AntibodiesIBA 01/2021 - 12/2002
4	Phosphotransferases (Kinase)IBA 01/2021 - 04/2015
4	Chlorambucil (Leukeran)FDA Link 01/2020 - 12/2015
4	Melphalan (Alkeran)FDA LinkGeneric 01/2017 - 07/2010
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2003
3	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 06/2004
3	idelalisibIBA 08/2021 - 01/2019
3	tafasitamabIBA 01/2021 - 01/2020
3	obinutuzumabIBA 01/2020 - 10/2015
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 09/2011
3	MicroRNAs (MicroRNA)IBA 01/2019 - 05/2011
3	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018 - 04/2015
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018 - 06/2010
3	Alemtuzumab (Campath)FDA Link 11/2015 - 12/2002
3	CytokinesIBA 01/2015 - 05/2008
3	Thalidomide (Thalomid)FDA Link 10/2014 - 07/2010
3	MethyltransferasesIBA 09/2009 - 01/2002
3	Death-Associated Protein KinasesIBA 09/2009 - 11/2003
2	IntegrinsIBA 04/2022 - 01/2016
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2022 - 05/2009
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
2	VaccinesIBA 01/2022 - 01/2019
2	Investigational DrugsIBA 01/2021 - 05/2017
2	ofatumumab FDA Link 11/2018 - 12/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018 - 02/2004
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2018 - 12/2016
2	Agammaglobulinaemia Tyrosine KinaseIBA 10/2018 - 12/2014
2	romiplostim FDA Link 03/2018 - 06/2014

Therapy/Procedure

52	Therapeutics 11/2022 - 12/2002
16	Drug Therapy (Chemotherapy) 11/2022 - 01/2003
9	Stem Cell Transplantation 01/2021 - 09/2009
6	Organ Transplantation 05/2010 - 11/2003
5	Transplantation 01/2019 - 03/2014
4	Precision Medicine 10/2021 - 01/2020
3	Time-to-Treatment 04/2015 - 01/2010
2	Radiotherapy 12/2020 - 01/2003
2	Autologous Transplantation 01/2020 - 04/2016
2	Hematopoietic Stem Cell Transplantation 01/2019 - 12/2009
2	Drug Tapering 12/2018 - 01/2017
2	Platelet Transfusion (Blood Platelet Transfusions) 03/2018 - 06/2014